Case Type: Mergers & Acquisitions

DallasNews Corporation (NASDAQ: DALN) related to its sale to Hearst Communications, Inc. for $14.00 in cash per share without interest to DallasNews shareholders.

Blueprint Medicines Corporation (NASDAQ: BPMC) related to its sale to Sanofi, S.A. Under the terms of the proposed transaction, Sanofi will pay $129.00 per share in cash at closing, and Blueprint shareholders also will receive one non-tradeable contingent value right (“CVR”) entitling the holder to receive two potential milestone payments of $2.00 and $4.00 per … Read more

Verona Pharma plc (NASDAQ: VRNA) related to its sale to Merck Sharp & Dohme LLC for $107.00 per American Depository Shares.

CARGO Therapeutics, Inc. (NASDAQ: CRGX) related to its sale to Concentra Biosciences, LLC for $4.379 in cash per CARGO share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and (ii) 80% of the net proceeds from the sale, … Read more

Core Scientific, Inc. (NASDAQ: CORZ) related to its sale to CoreWeave, Inc. Upon completion of the proposed transaction, each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock. Core Scientific shareholders will own less than 10% of the combined company.

PB Bankshares Inc. (NASDAQ: PBBK) related to its sale to Norwood Financial Corp. Under the terms of the proposed transaction, PB Bankshares’ shareholders will have the option to elect to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each common share of PB Bankshares they own. The election is subject … Read more

WNS (Holdings) Limited (NYSE: WNS) related to its sale to Capgemini, S.E. for $76.50 per share in cash to WNS shareholders.

Olo Inc. (NYSE: OLO) related to its sale to Thoma Bravo for $10.25 per share in cash to Olo shareholders.

Aimei Health Technology Co., Ltd (NASDAQ: AFJKU) related to its merger with United Hydrogen Global, Inc., in which Aimei shareholders will be eligible for either (i) a redemption of their shares for $10.00; or (ii) becoming Class A shareholders in the combined company with minimal voting influence.

Launch One Acquisition Corp. (NASDAQ: LPAA) related to its merger with Minovia Therapeutics Ltd., in which Launch One shareholders will be eligible for a one-to-one exchange of shares in the new company, Mito US One Ltd.